Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN ®: Results of two large phase 3 clinical studies

A prospective, randomised, multicentre, single-blind phase 3 study was performed to assess the safety of a vaccination schedule consisting of two vaccinations (21–35 days apart) with the tick-borne encephalitis (TBE) vaccine FSME-IMMUN ® “adults” (five consecutive lots) in comparison to another lice...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2006-06, Vol.24 (24), p.5256-5263
Hauptverfasser:	Loew-Baselli, A., Konior, R., Pavlova, B.G., Fritsch, S., Poellabauer, E., Maritsch, F., Harmacek, P., Krammer, M., Barrett, P.N., Ehrlich, H.J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Antibodies, Viral - blood Antigens Applied microbiology Arboviral encephalitis Arboviroses Biological and medical sciences Encephalitis Viruses, Tick-Borne - immunology Female Fever FSME-IMMUN ® vaccine Fundamental and applied biological sciences. Psychology Human viral diseases Humans Immunization Immunogenicity Infectious diseases Male Medical sciences Microbiology Middle Aged Mortality Neutralization Phase 3 clinical studies Safety Single-Blind Method Studies Tick-borne encephalitis Tropical viral diseases Vaccination Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Viral diseases Viral Vaccines - adverse effects Viral Vaccines - immunology Volunteers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!